Assessment of a serum assay for quantification of abdominal aortic calcification [1]

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 11, 2006, Pages 2574-2576

  Clancy, Paula ^a   Oliver, Lisa ^a   Jayalath, Rumal ^a   Buttner, Petra ^a   Golledge, Jonathan ^a  

^a JAMES COOK UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN; OSTEOPROTEGERIN;

ABDOMINAL AORTA; ARTERY CALCIFICATION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTERMETHOD COMPARISON; LETTER; PRIORITY JOURNAL;

AORTA, ABDOMINAL; AORTIC DISEASES; CALCINOSIS; GLYCOPROTEINS; HUMANS; OSTEOPONTIN; OSTEOPROTEGERIN; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; SEVERITY OF ILLNESS INDEX; SIALOGLYCOPROTEINS;

EID: 33750210372     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000242799.81434.7d     Document Type: Letter

References (9)

1. Jayalath RW, Mangan SH, Golledge J. Aortic calcification. Eur J Vasc Endovasc Surg. 2005;30:476-488.
2. Jayalath RW, Jackson P, Golledge J. Quantification of abdominal aortic calcification on CT. Arterioscler Thromb Vasc Biol. 2006;26:429-430.
3. Rhee EJ, Oh KW, Jung CH, Lee WY, Oh ES, Yun EJ, Baek KH, Kang MI, Kim SW. The relationship between four single nucleotide polymorphisms in the promoter region of the osteoprotegerin gene and aortic calcification or coronary artery disease in Koreans. Clin Endocrinol (Oxf). 2006;64:689-697.
4. Nitta K, Ishizuka T, Horita S, Hayashi T, Ajiro A, Uchida K, Honda K, Oba T, Kawashima A, Yumura W, Kabaya T, Akiba T, Nihei H. Soluble osteopontin and vascular calcification in hemodialysis patients. Nephron. 2001;89:455-458.
5. Linnet K. Necessary sample size for method comparison studies based on regression analysis. Clin Chem. 1999;45:882-894.
6. Bezerra MC, Calomeni GD, Caparbo VF, Gebrim ES, Rocha MS, Pereira RM Low bone density and low serum levels of soluble RANK ligand are associated with severe arterial calcification in patients with Takayasu arteritis. Rheumatology (Oxford). 2005;44:1503-1506.
7. Nitta K, Akiba T, Uchida K, Otsubo S, Takei T, Yumura W, Kabaya T, Nihei H. Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients. Nephrol Dial Transplant. 2004;19:1886-1889.
8. Nitta K, Akiba T, Uchida K, Otsubo S, Takei T, Yumura W, Kabaya T, Nihei H. The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. Am J Kidney Dis. 2003;42:303-309.
9. Kiechl S, Schett G, Wenning G, Redlich K, Oberhollenzer M, Mayr A, Santer P, Smolen J, Poewe W, Willeit J. Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation. 2004;109:2175-2180.